MedMira receives investigational testing authorization for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test

Halifax, Nova Scotia, 10.01.2025 (PresseBox) – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for…